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A B S T R A C T
Carbapenem-resistant Acinetobacter baumannii iso-
lates producing carbapenem-hydrolysing oxacil-
linases are emerging worldwide. These enzymes
are divided into four phylogenetic subgroups:
OXA-23-like, OXA-51-like, OXA-24-like and
OXA-58-like. A PCR-based approach linked to
pyrosequencing analysis was developed to iden-
tify the genes for these b-lactamases. Carbape-
nem-hydrolysing oxacillinases were rapidly and
unambiguously identified in a collection of carb-
apenem-resistant clinical isolates of A. baumannii
and Acinetobacter junii. Pyrosequencing may pro-
vide a rapid tool for identification of OXA
variants, thus avoiding delays inherent in clas-
sical sequencing methods.
Keywords Acinetobacter baumannii, b-lactamase, carb-
apenem resistance, identification, OXA variants, pyro-
sequencing
Original Submission: 15 March 2006; Revised Sub-
mission: 13 June 2006; Accepted: 27 June 2006
Clin Microbiol Infect 2006; 12: 1236–1240
10.1111/j.1469-0691.2006.01563.x
Carbapenems are the drugs of choice for treating
nosocomial infections caused by multidrug-resist-
ant Acinetobacter baumannii [1,2]. However, their
efficacy is being increasingly compromised as
carbapenem-resistant isolates are becoming wide-
spread in certain regions of the world [3–6]. A
variety of molecular resistance mechanisms to
carbapenems have been reported in A. baumannii,
including rare mutations in genes coding for
penicillin-binding proteins and alterations in
outer-membrane permeability, but the most com-
mon resistance mechanism involves the acquisi-
tion of carbapenem-hydrolysing b-lactamases
belonging to Ambler class B (metallo-enzymes)
and, predominantly, Ambler class D (oxacillinas-
es) [2,7,8].
The carbapenem-hydrolysing class D b-lacta-
mases (CHDLs) of Acinetobacter spp. are divided
into four phylogenetic subgroups: OXA-23-like,
OXA-24-like, OXA-51-like and OXA-58-like [8]. It
has been suggested that enzymes belonging to the
OXA-51-like subgroup may be intrinsic to A. bau-
mannii [9], based on their chromosomal location
and their ubiquitous distribution among A. bau-
mannii strains. Outbreaks of CHDL-producing
A. baumannii strains have been increasingly repor-
ted, involving, e.g., OXA-24 in Spain [7] and
OXA-40 in Spain and Portugal [10,11]; OXA-23 in
Brazil, French Polynesia, Spain, Korea and the UK
[12,13]; and OXA-58 worldwide [6,14,15]. The aim
of the present study was to develop a PCR-based
method for the detection of acquired blaOXA
genes, to be used in combination with pyro-
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sequencing to discriminate rapidly between the
OXA-23, OXA-24 and OXA-58 subgroups of
enzymes.
Pyrosequencing is a real-time DNA sequencing
method that, on average, analyses 50–60 bases by
detecting the release of pyrophosphate. It is faster,
less expensive and easier to perform than con-
ventional sequencing [16]. This technology has
been used previously for the detection of other
genes responsible for antibiotic resistance, e.g.,
fluoroquinolone resistance in Neisseria gonor-
rhoeae, rifampicin resistance in Mycobacterium
tuberculosis, macrolide resistance in Streptococcus
pneumoniae and Streptococcus pyogenes, and linezo-
lid resistance in enterococci [17,18].
The blaOXA-23 gene from A. baumannii Pap-1
[13], the blaOXA-40 gene from A. baumannii CLA-1
[10] and the blaOXA-58 gene from A. baumannii
MAD [15] were analysed as OXA variants repre-
sentative of the three subgroups of acquired
CHDLs in A. baumannii. An additional 50 carb-
apenem-resistant A. baumannii isolates and one
Acinetobacter junii isolate screened during the
study are listed in Table 1. The blaOXA-51-like gene
carried by A. baumannii AYE (blaVEB-1; blaAmpC;
blaOXA-69) [19], A. baumannii CIP7010 (blaAmpC;
blaOXA-69) (personal unpublished results) and
A. baumannii SDF (blaAmpC; blaOXA-76) [9] were
used as negative controls. Whole-cell DNA was
extracted by boiling a few colonies of each
bacterial strain resuspended in 100 lL of distilled
water. After 10 min at 100C, followed by freezing
at )80C for 5 min and boiling for an additional
5 min, the suspensions were centrifuged (5 min at
10 000 g) and 10 lL of supernatant was used in
100-lL PCR experiments. After initial denatura-
tion at 94C for 12 min, amplification comprised
30 s at 94C, 30 s at 53C and 45 s at 72C. Specific
primers (OXA-F, 5¢-CGMGCAAAWAMAGMW-
TAT, and OXA-R1bio, 5¢-ARABCCATTSCCCAD-
CCA) were chosen to amplify a 457-bp fragment
from all the acquired blaOXA genes studied, but
not from the naturally occurring blaOXA-51-like
genes [9,20] (Fig. S1; see Supplementary material).
Sequencing primers were S-OXA-deg (5¢-CCW-
GCMTCWACATTTAA), which is a degenerate
primer that allows sequence determination of all
three target genes, and three sequencing primers
that were specific for each sequence and were
used in an equimolar mixture (S-OXA-Mix) com-
prising S-OXA-40 (5¢-CCTGCATCAACATTTAA),
S-OXA-23 (5¢-CCAGCCTCTACATTTAA) and S-
OXA-58 (5¢-CCTGCATCTACATTTAA). Reverse
primers were biotin-labelled at their 5¢-end. All of
the primers and probes used for pyrosequencing
were purified by HPLC (Sigma Proligo, Saint-
Quentin-Fallavier, France).
Pyrosequencing was performed using a PSQ 96
sample preparation kit and a PSQ 96MA analyser
(AB Biotage, Uppsala, Sweden), according to the
manufacturer’s instructions. A single PCR prod-
uct of high intensity was obtained for each strain
with an acquired blaOXA gene, while no PCR
product was obtained with the two control
strains, suggesting that the primers were specific
for the acquired enzymes (Fig. 1a). Unpurified
PCR products (20 lL) were captured using strept-
avidin–sepharose beads, and the resulting single-
stranded DNA was used as a template for
pyrosequencing reactions, with either the degen-
erate pyrosequencing primer or the mixture of
three specific pyrosequencing primers, based on
a protocol detailed at http://www.pyrosequenc-
ing.com. The different pyrograms obtained with
the three variants tested are shown in Figs 1b–d.
The light released at each extension step is
directly proportional to the amount of nucleotide
added, with the relative amount of a given
nucleotide being calculated from the relative
peak heights. Pyrosequencing allowed the three
b-lactamase variants to be distinguished in
<20 min. Interestingly, the primer mixture gave
Table 1. Pyrosequencing results for known imipenem-non-susceptible clinical isolates of Acinetobacter baumannii and
Acinetobacter junii
Country of origin City of outbreak Species (n) blaOXA gene Ref. Pyrosequence
a Identification
France Toulouse A. baumannii (7) blaOXA-58 [14] AATTGCCAATC OXA-58
Papeete A. baumannii (24) blaOXA-23 [13] AATGTTGAATGCCCT OXA-23
Spain Seville A. baumannii (7) blaOXA-58 [14] AATTGCCAATC OXA-58
Barcelona A. baumannii (12) blaOXA-40 [14] GATGCTAAATGCTTT OXA-40
Roumania Bucarest A. junii (1) blaOXA-23 and
blaOXA-58
[14] AATTGctgAATgCCC OXA-23
and OXA-58
aSmall letters represent nucleotides that derive from either blaOXA-58 or blaOXA-23.
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Fig. 1. (a) Agarose gel analysis of PCR products amplified from the OXA-producing Acinetobacter baumanii strains tested.
Lanes: 1, blaOXA-40 gene [10]; 2, blaOXA-58 gene [15]; 3, blaOXA-23 gene [13]; 4, blaVEB-1 gene [19]; 5, negative control
A. baumannii strain CIP7010. PCR products were obtained with OXA-F and OXA-R1bio primers (expected size, 457 bp). M
corresponds to the molecular size marker (1-kb ladder; Invitrogen, Carlsbad, CA, USA). (b) Detection by pyrosequencing of
the blaOXA-40, blaOXA-58 and blaOXA-23 genes using the OXA sequencing primer mixture. (c) Detection by pyrosequencing of
blaOXA-40 using the OXA-deg sequencing primer. The deduced sequence is indicated above each peak for the blaOXA gene.
(d) Detection by pyrosequencing of blaOXA-23 and blaOXA-58 in Acinetobacter junii. Grey boxes represent peaks that are
specific for each blaOXA gene as indicated. Control pyrograms specific for OXA-23 and OXA-58 are indicated on each side of
the A. junii pyrogram.
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better pyrosequencing results than the degenerate
primer, as shown by the relative peak heights
obtained for blaOXA-40 sequenced with S-OXA-deg
and S-OXA-Mix (Figs 1b and c).
As a high-throughput sequencing technique (96
sequencing reactions in one run), pyrosequencing
allowed screening of 51 Acinetobacter isolates in
<20 min. The expected identification was ob-
tained for all the isolates tested, with the complex
pyrogram obtained for the A. junii isolate reflect-
ing the presence of both blaOXA-58 and blaOXA-23
(Table 1; Fig. 1d). Thus, the method presented
here is a rapid tool for identification of acquired
carbapenem-hydrolysing OXA-type enzymes.
The PCR assay was able to amplify the known
acquired blaOXA genes, but not the naturally
occurring blaOXA-51-like genes. Pyrosequencing,
performed as a complementary step, allowed
identification of the precise OXA subgroup pre-
sent in clinical A. baumannii isolates within a few
minutes. The output data from pyrosequencing is
a reference standard of genetic information, i.e.,
real sequence data, which is the best assurance of
a correct test. From extraction to sequence deter-
mination, the complete manual technique re-
quired <3 h, which could be reduced even
further by using a faster PCR technique and by
automation (http://www.pyrosequencing.com).
Thus, in geographical areas where different
OXA variants are known to coexist, e.g., France,
the UK and Spain, pyrosequencing may provide a
rapid epidemiological tool for rapid identification
of OXA variants, thus avoiding delays inherent in
classical sequencing methods.
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